Filing Flows

Filing Flows › Comparisons › IDXX vs QDEL

Idexx Laboratories vs QuidelOrtho: IDXX and QDEL compared

Idexx Laboratories is the larger company: $1.2B of revenue in its latest quarter (Q3 2026) against $619M for QuidelOrtho (Q3 2026). Idexx Laboratories is growing faster (+10% against -12% a year earlier). Idexx Laboratories is more profitable, with an operating margin of 33.1% against -1.2%.

Idexx Laboratories vs QuidelOrtho, latest quarterIdexx Laboratories vs QuidelOrtho, latest quarterIdexx Laboratories (IDXX)QuidelOrtho (QDEL)Revenue$1.2B$619MRevenue growth, Y/Y+10%-12%Operating margin33.1%-1.2%Net margin26.1%-8.7%Free cash flow$421M$300K

Where the money goes: IDXX and QDEL

Idexx Laboratories (IDXX) · Q3 2026

Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.

QuidelOrtho (QDEL) · Q3 2026

QuidelOrtho, Q3 2026: revenue $619M (-12% year over year), operating margin -1.2%, net loss $53.8M, operating cash flow $19.6M. The chart follows the revenue to costs, profit and cash.

Idexx Laboratories revenue by segment, Q3 2026Idexx Laboratories revenue by segment, Q3 2026Product revenue$723MService revenue$491M
Idexx Laboratories (IDXX)QuidelOrtho (QDEL)
Latest quarterQ3 2026Q3 2026
Revenue$1.2B$619M
Revenue growth, Y/Y+10%-12%
Gross margin62.9%—
Operating margin33.1%-1.2%
Net earnings$317M−$53.8M
Net margin26.1%-8.7%
Operating cash flow$450M$19.6M
Free cash flow$421M$300K
Market value$53.5B$735M
P/E45.6×—
Analysts’ mean target$717.17$14.67

Where the revenue comes from

Idexx Laboratories

Questions

Which is bigger, Idexx Laboratories or QuidelOrtho?

Idexx Laboratories is the larger company: $1.2B of revenue in its latest quarter (Q3 2026) against $619M for QuidelOrtho (Q3 2026).

Is Idexx Laboratories or QuidelOrtho growing faster?

Idexx Laboratories is growing faster (+10% against -12% a year earlier).

Which is more profitable, Idexx Laboratories or QuidelOrtho?

Idexx Laboratories is more profitable, with an operating margin of 33.1% against -1.2%.

More: Idexx Laboratories earnings · how Idexx Laboratories makes money · QuidelOrtho earnings · how QuidelOrtho makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 2, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.